Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.

Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a ...

A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated cancer antigen levels at diagnosis.

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...

Researchers found that Black and Native American patients were 23% less likely to have high levels of CA-125 when diagnosed with ovarian cancer compared to white patients. That means the test may miss ...

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients with ovarian cancer.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current ...

The study, published in JAMA Network Open, looked at more than 200,000 women with ovarian cancer who took a test called CA-125. This test checks for a tumor marker in the blood that can be a sign ...